[S02DA03, antipyrine, The excretion of Stavudine can be decreased when combined with Antipyrine.]
[M03AB01, succinylcholine, Succinylcholine may increase the neurotoxic activities of Stavudine.]
[J01EC01, sulfamethoxazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Sulfamethoxazole.]
[M01AB02, sulindac, The excretion of Stavudine can be decreased when combined with Sulindac.]
[N05AL01, sulpiride, Sulpiride may increase the neurotoxic activities of Stavudine.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Stavudine.]
[L01CB02, teniposide, Teniposide may increase the neurotoxic activities of Stavudine.]
[S03AA02, tetracycline, The excretion of Stavudine can be decreased when combined with Tetracycline.]
[N05AE05, lurasidone, Stavudine may increase the neurotoxic activities of Lurasidone.]
[R06AD03, thiethylperazine, Thiethylperazine may increase the neurotoxic activities of Stavudine.]
[N05AB08, thioproperazine, Stavudine may increase the neurotoxic activities of Thioproperazine.]
[N05AC02, thioridazine, Stavudine may increase the neurotoxic activities of Thioridazine.]
[N05AF04, thiothixene, Stavudine may increase the neurotoxic activities of Thiothixene.]
[N05AL03, tiapride, Stavudine may increase the neurotoxic activities of Tiapride.]
[V04CA01, tolbutamide, The excretion of Stavudine can be decreased when combined with Tolbutamide.]
[M02AA21, tolmetin, The excretion of Stavudine can be decreased when combined with Tolmetin.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triamcinolone is combined with Stavudine.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Triazolam.]
[N05AB06, trifluoperazine, Stavudine may increase the neurotoxic activities of Trifluoperazine.]
[S01AD02, trifluridine, The excretion of Stavudine can be decreased when combined with Trifluridine.]
[N05AD02, trifluperidol, Stavudine may increase the neurotoxic activities of Trifluperidol.]
[N05AA05, triflupromazine, Triflupromazine may increase the neurotoxic activities of Stavudine.]
[R06AD01, trimeprazine, Stavudine may increase the neurotoxic activities of Alimemazine.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Stavudine.]
[N06AA06, trimipramine, Stavudine may increase the neurotoxic activities of Trimipramine.]
[M03AA02, tubocurarine, Stavudine may increase the neurotoxic activities of Tubocurarine.]
[L01CA02, vincristine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Stavudine.]
[S01AA13, fusidic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Fusidic acid.]
[J05AF01, zidovudine, The therapeutic efficacy of Stavudine can be decreased when used in combination with Zidovudine.]
[N05AF05, zuclopenthixol, Stavudine may increase the neurotoxic activities of Zuclopenthixol.]
[J05AE02, indinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Stavudine.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Stavudine.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Ibandronate.]
[N05AE04, ziprasidone, Ziprasidone may increase the neurotoxic activities of Stavudine.]
[N02BA01, aspirin, The excretion of Stavudine can be decreased when combined with Acetylsalicylic acid.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Stavudine.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Stavudine.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Stavudine.]
[N01AA01, ethyl ether, Stavudine may increase the neurotoxic activities of Diethyl ether.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Stavudine.]
[N05AD07, benperidol, Stavudine may increase the neurotoxic activities of Benperidol.]
[J02AX04, caspofungin, The excretion of Stavudine can be decreased when combined with Caspofungin.]
[L01EC02, dabrafenib, The excretion of Stavudine can be decreased when combined with Dabrafenib.]
[J05AJ03, dolutegravir, The excretion of Stavudine can be decreased when combined with Dolutegravir.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Stavudine.]
[C10AB02, bezafibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Bezafibrate.]
[N07XX08, tafamidis, The excretion of Stavudine can be decreased when combined with Tafamidis.]
[N05AA04, acepromazine, Stavudine may increase the neurotoxic activities of Acepromazine.]
[S03AA06, gentamicin, The excretion of Stavudine can be decreased when combined with Gentamicin.]
[L01EX08, lenvatinib, The excretion of Stavudine can be decreased when combined with Lenvatinib.]
[J05AF08, adefovir dipivoxil, The excretion of Stavudine can be decreased when combined with Adefovir dipivoxil.]
[N05AX16, brexpiprazole, Stavudine may increase the neurotoxic activities of Brexpiprazole.]
[N05AX15, cariprazine, Stavudine may increase the neurotoxic activities of Cariprazine.]
[S01EC01, acetazolamide, The excretion of Stavudine can be decreased when combined with Acetazolamide.]
[N05AB07, acetophenazine, Stavudine may increase the neurotoxic activities of Acetophenazine.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Acipimox.]
[L01CX01, trabectedin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Trabectedin.]
[N06AA19, amineptin, Stavudine may increase the neurotoxic activities of Amineptine.]
[N05AX17, pimavanserin, Stavudine may increase the neurotoxic activities of Pimavanserin.]
[C03CA02, bumetanide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Bumetanide.]
[J01XX08, linezolid, The excretion of Stavudine can be decreased when combined with Linezolid.]
[L04AB02, infliximab, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Stavudine.]
[L01XX59, enasidenib, The excretion of Stavudine can be decreased when combined with Enasidenib.]
[A02BX12, bismuth subnitrate, Stavudine may increase the neurotoxic activities of Bismuth subnitrate.]
[N05AD06, bromperidol, Stavudine may increase the neurotoxic activities of Bromperidol.]
[N06AA15, butriptyline, Stavudine may increase the neurotoxic activities of Butriptyline.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Captopril.]
[J01CA03, carbenicillin, The excretion of Stavudine can be decreased when combined with Carbenicillin.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Stavudine.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Ciprofibrate.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Ubidecarenone.]
[J01DB05, cefadroxil, The excretion of Stavudine can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Stavudine can be decreased when combined with Cefamandole.]
[J01DB04, cefazolin, The excretion of Stavudine can be decreased when combined with Cefazolin.]
[J01DD12, cefoperazone, The excretion of Stavudine can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Stavudine can be decreased when combined with Cefotaxime.]
[N05AA06, cyamemazine, Stavudine may increase the neurotoxic activities of Cyamemazine.]
[J01DC07, cefotiam, The excretion of Stavudine can be decreased when combined with Cefotiam.]
[J01DD07, ceftizoxime, The excretion of Stavudine can be decreased when combined with Ceftizoxime.]
[J01DD04, ceftriaxone, The excretion of Stavudine can be decreased when combined with Ceftriaxone.]
[M03BX08, cyclobenzaprine, Stavudine may increase the neurotoxic activities of Cyclobenzaprine.]
[N04CX01, istradefylline, The excretion of Stavudine can be decreased when combined with Istradefylline.]
[C03AA09, cyclothiazide, The excretion of Stavudine can be decreased when combined with Cyclothiazide.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Stavudine.]
[J01DB01, cephalexin, The excretion of Stavudine can be decreased when combined with Cephalexin.]
[J01DB03, cephalothin, The excretion of Stavudine can be decreased when combined with Cefalotin.]
[J01DB09, cephradine, The excretion of Stavudine can be decreased when combined with Cefradine.]
[S03AA08, chloramphenicol, The excretion of Stavudine can be decreased when combined with Chloramphenicol.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Stavudine.]
[L01EX23, pralsetinib, The excretion of Stavudine can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, The excretion of Stavudine can be decreased when combined with Chlorothiazide.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the neurotoxic activities of Stavudine.]
[A10BB02, chlorpropamide, The excretion of Stavudine can be decreased when combined with Chlorpropamide.]
[N05AF03, chlorprothixene, Stavudine may increase the neurotoxic activities of Chlorprothixene.]
[M01AB08, etodolac, The excretion of Stavudine can be decreased when combined with Etodolac.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Etofibrate.]
[L01FX21, naxitamab, Stavudine may increase the neurotoxic activities of Naxitamab.]
[J05AJ04, cabotegravir, The excretion of Stavudine can be decreased when combined with Cabotegravir.]
[S01JA01, fluorescein, The excretion of Stavudine can be decreased when combined with Fluorescein.]
[A02BA01, cimetidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cimetidine is combined with Stavudine.]
[J01MB06, cinoxacin, The excretion of Stavudine can be decreased when combined with Cinoxacin.]
[S03AA07, ciprofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Stavudine.]
[P01CA03, fexinidazole, The excretion of Stavudine can be decreased when combined with Fexinidazole.]
[J01FF01, clindamycin, Stavudine may increase the neurotoxic activities of Clindamycin.]
[C10AB01, clofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Stavudine.]
[N06AA04, clomipramine, Stavudine may increase the neurotoxic activities of Clomipramine.]
[N05AH06, clothiapine, Stavudine may increase the neurotoxic activities of Clothiapine.]
[N05AH02, clozapine, Clozapine may increase the neurotoxic activities of Stavudine.]
[R05DA04, codeine, The excretion of Stavudine can be decreased when combined with Codeine.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Colchicine.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Leflunomide.]
[A10BX03, nateglinide, The excretion of Stavudine can be decreased when combined with Nateglinide.]
[J05AB14, valganciclovir, The risk or severity of cytopenia can be increased when Valganciclovir is combined with Stavudine.]
[S01AD03, acyclovir, The excretion of Stavudine can be decreased when combined with Acyclovir.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Nafarelin.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Mebeverine.]
[N05AD03, metylperon, Stavudine may increase the neurotoxic activities of Melperone.]
[L01AA01, cyclophosphamide, Cyclophosphamide may increase the neurotoxic activities of Stavudine.]
[J04AB01, cycloserine, Cycloserine may increase the neurotoxic activities of Stavudine.]
[S01XA18, cyclosporine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Stavudine.]
[C10AA07, rosuvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Rosuvastatin.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Cytarabine.]
[J04BA02, dapsone, The risk or severity of peripheral neuropathy can be increased when Stavudine is combined with Dapsone.]
[N06AA01, desipramine, Stavudine may increase the neurotoxic activities of Desipramine.]
[S03BA01, dexamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Dexamethasone.]
[N06AA08, dibenzepin, Stavudine may increase the neurotoxic activities of Dibenzepin.]
[S01BC03, diclofenac, The excretion of Stavudine can be decreased when combined with Diclofenac.]
[J05AD01, foscarnet, The excretion of Stavudine can be decreased when combined with Foscarnet.]
[J05AF02, didanosine, The risk or severity of adverse effects can be increased when Stavudine is combined with Didanosine.]
[N05AD05, pipamperone, Stavudine may increase the neurotoxic activities of Pipamperone.]
[N02BA11, diflunisal, The excretion of Stavudine can be decreased when combined with Diflunisal.]
[G02AD02, dinoprostone, The excretion of Stavudine can be decreased when combined with Dinoprostone.]
[N06AA23, quinupramine, Stavudine may increase the neurotoxic activities of Quinupramine.]
[N05AL04, remoxipride, Remoxipride may increase the neurotoxic activities of Stavudine.]
[N05AX08, risperidone, Stavudine may increase the neurotoxic activities of Risperidone.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Salmeterol.]
[N06AA16, dothiepin, Stavudine may increase the neurotoxic activities of Dosulepin.]
[N06AA12, doxepin, Stavudine may increase the neurotoxic activities of Doxepin.]
[L01DB01, doxorubicin, The therapeutic efficacy of Stavudine can be decreased when used in combination with Doxorubicin.]
[N05AD08, droperidol, Droperidol may increase the neurotoxic activities of Stavudine.]
[C10AA01, simvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Simvastatin is combined with Stavudine.]
[N05AL02, sultopride, Stavudine may increase the neurotoxic activities of Sultopride.]
[J01CG02, tazobactam, The excretion of Stavudine can be decreased when combined with Tazobactam.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Terbinafine.]
[N05AB05, thiopropazate, Stavudine may increase the neurotoxic activities of Thiopropazate.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Tianeptine.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Stavudine.]
[N05AL06, veralipride, Stavudine may increase the neurotoxic activities of Veralipride.]
[L01CA04, vinorelbine, Vinorelbine may increase the neurotoxic activities of Stavudine.]
[N05AX11, zotepine, Stavudine may increase the neurotoxic activities of Zotepine.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Iloprost.]
[C01BG01, moricizine, Stavudine may increase the neurotoxic activities of Moricizine.]
[N03AG01, valproic acid, The excretion of Stavudine can be decreased when combined with Valproic acid.]
[C10AA04, fluvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Fluvastatin.]
[N05AE03, sertindole, Stavudine may increase the neurotoxic activities of Sertindole.]
[L04AD02, tacrolimus, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Tacrolimus.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Stavudine.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Stavudine.]
[C10AA03, pravastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Stavudine.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Stavudine.]
[N06AA14, melitracen, Stavudine may increase the neurotoxic activities of Melitracen.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Ethanol.]
[N05AF01, flupenthixol, Stavudine may increase the neurotoxic activities of Flupentixol.]
[N05AB02, fluphenazine, Fluphenazine may increase the neurotoxic activities of Stavudine.]
[S01BC04, flurbiprofen, The excretion of Stavudine can be decreased when combined with Flurbiprofen.]
[N05AG01, fluspirilene, Stavudine may increase the neurotoxic activities of Fluspirilene.]
[V04CX02, folic acid, The excretion of Stavudine can be decreased when combined with Folic acid.]
[C03CA01, furosemide, The excretion of Stavudine can be decreased when combined with Furosemide.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Stavudine.]
[N05AL05, amisulpride, Stavudine may increase the neurotoxic activities of Amisulpride.]
[M03AC02, gallamine, Stavudine may increase the neurotoxic activities of Gallamine.]
[S01AD09, ganciclovir, The risk or severity of cytopenia can be increased when Ganciclovir is combined with Stavudine.]
[C10AB04, gemfibrozil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Gemfibrozil.]
[A10BB01, glyburide, The excretion of Stavudine can be decreased when combined with Glyburide.]
[N05AD01, haloperidol, Haloperidol may increase the neurotoxic activities of Stavudine.]
[C09CA01, losartan, The excretion of Stavudine can be decreased when combined with Losartan.]
[C03AA03, hydrochlorothiazide, The excretion of Stavudine can be decreased when combined with Hydrochlorothiazide.]
[N05AX07, prothipendyl, Stavudine may increase the neurotoxic activities of Prothipendyl.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Stavudine.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Risedronic acid.]
[R02AX02, ibuprofen, The excretion of Stavudine can be decreased when combined with Ibuprofen.]
[B05CB02, sodium citrate, Stavudine may increase the neurotoxic activities of Sodium citrate.]
[N06AA02, imipramine, Imipramine may increase the neurotoxic activities of Stavudine.]
[L01CD01, paclitaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Paclitaxel.]
[S01BC01, indomethacin, The excretion of Stavudine can be decreased when combined with Indomethacin.]
[C10AA06, cerivastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cerivastatin is combined with Stavudine.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Ipecac.]
[N06AA13, iprindole, Stavudine may increase the neurotoxic activities of Iprindole.]
[G04BE01, alprostadil, The excretion of Stavudine can be decreased when combined with Alprostadil.]
[N05AA07, chlorproethazine, Stavudine may increase the neurotoxic activities of Chlorproethazine.]
[J04AC01, isoniazid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Isoniazid.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Isotretinoin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Stavudine.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Stavudine.]
[M02AA10, ketoprofen, The excretion of Stavudine can be decreased when combined with Ketoprofen.]
[J01MB02, nalidixic acid, The excretion of Stavudine can be decreased when combined with Nalidixic acid.]
[J01FF02, lincomycin, Stavudine may increase the neurotoxic activities of Lincomycin.]
[N06AA07, lofepramine, Stavudine may increase the neurotoxic activities of Lofepramine.]
[C10AA02, lovastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lovastatin is combined with Stavudine.]
[N05AH01, loxapine, Loxapine may increase the neurotoxic activities of Stavudine.]
[M02AA18, meclofenamic acid, The excretion of Stavudine can be decreased when combined with Meclofenamic acid.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Stavudine.]
[N05AC03, mesoridazine, Stavudine may increase the neurotoxic activities of Mesoridazine.]
[N05AX13, paliperidone, Stavudine may increase the neurotoxic activities of Paliperidone.]
[N07BC02, methadone, The serum concentration of Stavudine can be decreased when it is combined with Methadone.]
[S01EC05, methazolamide, The excretion of Stavudine can be decreased when combined with Methazolamide.]
[L04AX03, methotrexate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methotrexate is combined with Stavudine.]
[N05AA02, methotrimeprazine, Stavudine may increase the neurotoxic activities of Methotrimeprazine.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Methyldopa.]
[V04CG05, methylene blue, Stavudine may increase the neurotoxic activities of Methylene blue.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Metoclopramide.]
[N02BB03, aminopyrine, The excretion of Stavudine can be decreased when combined with Aminophenazone.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Minocycline.]
[N05AE02, molindone, Stavudine may increase the neurotoxic activities of Molindone.]
[C01BD01, amiodarone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may increase the neurotoxic activities of Stavudine.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Raltegravir.]
[N06AA17, amoxapine, Amoxapine may increase the neurotoxic activities of Stavudine.]
[J01CA04, amoxicillin, The excretion of Stavudine can be decreased when combined with Amoxicillin.]
[J01CF06, nafcillin, The excretion of Stavudine can be decreased when combined with Nafcillin.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Naltrexone.]
[M02AA12, naproxen, The excretion of Stavudine can be decreased when combined with Naproxen.]
[L01CD02, docetaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Docetaxel.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Letrozole.]
[S03AA01, neomycin, Stavudine may increase the neurotoxic activities of Neomycin.]
[N05AX14, iloperidone, Stavudine may increase the neurotoxic activities of Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Amphotericin B.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Stavudine.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Norfloxacin.]
[N06AA10, nortriptyline, Nortriptyline may increase the neurotoxic activities of Stavudine.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Ofloxacin.]
[N06AA05, opipramol, Stavudine may increase the neurotoxic activities of Opipramol.]
[N05AE01, oxypertine, Stavudine may increase the neurotoxic activities of Oxypertine.]
[S01BC02, oxyphenbutazone, The excretion of Stavudine can be decreased when combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The excretion of Stavudine can be decreased when combined with Oxytetracycline.]
[V04CH30, 4-aminohippuric acid, The excretion of Stavudine can be decreased when combined with Aminohippuric acid.]
[N05AH05, asenapine, Stavudine may increase the neurotoxic activities of Asenapine.]
[N05AG03, penfluridol, Stavudine may increase the neurotoxic activities of Penfluridol.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Penicillamine.]
[S01AA14, penicillin G, The excretion of Stavudine can be decreased when combined with Benzylpenicillin.]
[N05AB10, perazine, Stavudine may increase the neurotoxic activities of Perazine.]
[N05AB03, perphenazine, Stavudine may increase the neurotoxic activities of Perphenazine.]
[N02BE03, phenacetin, The excretion of Stavudine can be decreased when combined with Phenacetin.]
[M02AA01, phenylbutazone, The excretion of Stavudine can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Stavudine.]
[J05AB12, cidofovir, The excretion of Stavudine can be decreased when combined with Cidofovir.]
[N05AG02, pimozide, Stavudine may increase the neurotoxic activities of Pimozide.]
[C10AA05, atorvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Atorvastatin.]
[J01CA12, piperacillin, The excretion of Stavudine can be decreased when combined with Piperacillin.]
[J05AE01, saquinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Saquinavir.]
[N05AC04, pipothiazine, Stavudine may increase the neurotoxic activities of Pipotiazine.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Eprosartan.]
[S01BC06, piroxicam, The excretion of Stavudine can be decreased when combined with Piroxicam.]
[S03AA03, polymyxin B, Stavudine may increase the neurotoxic activities of Polymyxin B.]
[J05AE03, ritonavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ritonavir is combined with Stavudine.]
[C10AA08, pitavastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Pitavastatin.]
[M04AB01, probenecid, The excretion of Stavudine can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Procainamide.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Fenofibrate.]
[N05AB04, prochlorperazine, Prochlorperazine may increase the neurotoxic activities of Stavudine.]
[N05AA03, promazine, Promazine may increase the neurotoxic activities of Stavudine.]
[R06AD02, promethazine, Stavudine may increase the neurotoxic activities of Promethazine.]
[N05AC01, periciazine, Stavudine may increase the neurotoxic activities of Periciazine.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Propofol.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Stavudine.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Stavudine.]
[N06AA11, protriptyline, Protriptyline may increase the neurotoxic activities of Stavudine.]
[N05AX12, aripiprazole, Stavudine may increase the neurotoxic activities of Aripiprazole.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Ranitidine.]
[C02AA02, reserpine, Reserpine may increase the neurotoxic activities of Stavudine.]
[J05AP01, ribavirin, Ribavirin may increase the hepatotoxic activities of Stavudine.]
[S01XA26, riboflavin, The excretion of Stavudine can be decreased when combined with Riboflavin.]
[J04AB02, rifampin, The excretion of Stavudine can be decreased when combined with Rifampicin.]
[S01BC08, salicylic acid, The excretion of Stavudine can be decreased when combined with Salicylic acid.]
[C03CC01, ethacrynic acid, The excretion of Stavudine can be decreased when combined with Etacrynic acid.]
